Loading clinical trials...

COMPLETEDPhase 4NCT03842436

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

This study deploys a novel digital pill with Emtricitabine/Tenofovir (TDF/FTC) among MSM with substance use to monitor PrEP adherence. The investigators will enroll N=15 HIV uninfected MSM with self r...

Lead sponsor: Brigham and Women's Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Family Support Protocol for Adolescent Internalizing Disorders

NCT06413979 · Internalizing Disorders, Substance Use Disorders

RECRUITINGNA

Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

NCT05613010 · Transplant;Failure,Kidney, Transplant; Failure, Liver, and more

RECRUITINGNA

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

NCT05492825 · Substance Use Disorders, Chronic Pain, and more

RECRUITINGNA

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

NCT04197921 · Opioid-use Disorder, Substance Use Disorders

RECRUITINGNA

Appalachian Partnership to Reduce Disparities (Aim 2)

NCT04378439 · HIV/AIDS, STI, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 22, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment16

Start dateOct 2018

Last updatedDec 22, 2022

Condition

HIV/AIDS Substance Use Disorders Adherence, Medication

Locations shown

Fenway Health

Boylston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Family Support Protocol for Adolescent Internalizing Disorders

Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

Appalachian Partnership to Reduce Disparities (Aim 2)

Trial snapshot

Condition

Locations shown

For caregivers